ACE2 and cardiovascular disorder: Although the mechanism is still unknown, it is essential to be aware of any unfavorable or deleterious effects of Mas activation in the kidney, when the therapeutic potential of ACE2/Ang (1–7)/Mas in metabolic or cardiovascular diseases is widely noticed.